World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
The University of Pennsylvania, Penn Epigenetics Institute, Systems Pharmacology & Translational Therapeutics
Showing your local timezone
Schedule
Wednesday, October 6, 2021
7:00 PM Europe/Berlin
Recording provided by the organiser.
Domain
NeuroscienceOriginal Event
View sourceHost
Neuroepigenetics Series
Duration
60 minutes
Neuronal alternative splicing is a key gene regulatory mechanism in the brain. However, the spliceosome machinery is insufficient to fully specify splicing complexity. In considering the role of the epigenome in activity-dependent alternative splicing, we and others find the histone modification H3K36me3 to be a putative splicing regulator. In this study, we found that mouse cocaine self-administration caused widespread differential alternative splicing, concomitant with the enrichment of H3K36me3 at differentially spliced junctions. Importantly, only targeted epigenetic editing can distinguish between a direct role of H3K36me3 in splicing and an indirect role via regulation of splice factor expression elsewhere on the genome. We targeted Srsf11, which was both alternatively spliced and H3K36me3 enriched in the brain following cocaine self-administration. Epigenetic editing of H3K36me3 at Srsf11 was sufficient to drive its alternative splicing and enhanced cocaine self-administration, establishing the direct causal relevance of H3K36me3 to alternative splicing of Srsf11 and to reward behavior.
Elizabeth A Heller, PhD
The University of Pennsylvania, Penn Epigenetics Institute, Systems Pharmacology & Translational Therapeutics
Contact & Resources